The Role of Glutamate Neurotransmission in the Ventral Tegmental Area in the Expression of Conditioned Approach Learning by Hachimine-Merli, Priscila
City University of New York (CUNY)
CUNY Academic Works
Dissertations, Theses, and Capstone Projects Graduate Center
9-2017
The Role of Glutamate Neurotransmission in the
Ventral Tegmental Area in the Expression of
Conditioned Approach Learning
Priscila Hachimine-Merli
The Graduate Center, City University of New York
How does access to this work benefit you? Let us know!
Follow this and additional works at: https://academicworks.cuny.edu/gc_etds
Part of the Behavioral Neurobiology Commons, Biological Psychology Commons, Cognitive
Neuroscience Commons, and the Systems Neuroscience Commons
This Dissertation is brought to you by CUNY Academic Works. It has been accepted for inclusion in All Dissertations, Theses, and Capstone Projects
by an authorized administrator of CUNY Academic Works. For more information, please contact deposit@gc.cuny.edu.
Recommended Citation
Hachimine-Merli, Priscila, "The Role of Glutamate Neurotransmission in the Ventral Tegmental Area in the Expression of
Conditioned Approach Learning" (2017). CUNY Academic Works.
https://academicworks.cuny.edu/gc_etds/2249
  
 
 
 
 
 
 
 
 
 
THE ROLE OF GLUTAMATE NEUROTRANSMISSION IN THE VENTRAL TEGMENTAL AREA IN THE 
EXPRESSION OF CONDITIONED APPROACH LEARNING 
 
 
 
by 
 
 
 
PRISCILA HACHIMINE-MERLI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A dissertation submitted to the Graduate Faculty in Psychology in partial fulfillment of the requirements for 
the degree of Doctor of Philosophy,  
The City University of New York 
 
2017 
 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2017 
Priscila Hachimine 
All Rights Reserved 
 
 
iii 
 
THE ROLE OF GLUTAMATE NEUROTRANSMISSION IN THE VENTRAL  
TEGMENTAL AREA IN THE EXPRESSION OF CONDITIONED APPROACH LEARNING 
 
By  
 
PRISCILA HACHIMINE-MERLI 
 
This manuscript has been read and accepted by the Graduate Faculty in Neuropsychology in satisfaction 
of the dissertation requirement for the degree of Doctor of Philosophy. 
 
 
 
 
________________   _________________________________ 
Date     Dr. Robert Ranaldi 
Chair of Examining Committee 
 
 
 
________________   _________________________________ 
Date     Dr. Richard Bodnar 
Executive Officer 
 
 
  
     Dr. Richard Bodnar 
 
     Dr. Carolyn Pytte  
 
     Dr. Jon Horvitz 
 
Dr. John Robinson 
 
Supervisory Committee 
 
THE CITY UNIVERSITY OF NEW YORK
 
 
iv 
 
Abstract 
 
THE ROLE OF GLUTAMATE NEUROTRANSMISSION IN THE VENTRAL TEGMENTAL AREA IN THE 
EXPRESSION OF CONDITIONED APPROACH LEARNING 
by 
Priscila Hachimine 
 
Advisor: Robert Ranaldi, Ph.D.  
 
Conditioned stimuli (CSs) come to function as CSs by acquiring the capacity to activate the same 
mesocorticolimbic dopamine (DA) neurons activated by primary rewards, producing conditioned activation 
of these neurons and their associated motivational states. This model stipulates that CSs activate 
mesocorticolimbic DA systems through the activation of glutamate receptors on DA neurons in the ventral 
tegmental area (VTA). We tested the hypothesis that glutamate receptor stimulation in the VTA is 
necessary for the expression of conditioned approach. Rats were tested in a conditioned approach 
protocol that consisted of 7 consecutive conditioning sessions (light presentations and food were paired), 
one session with no light or food and one test session with only light stimulus (CS-only) presentations. 
The number of head entries during the CS and pre-CS (baseline) periods was used to calculate 
difference scores. Bilateral VTA microinjections of glutamate receptor antagonists were made prior to the 
CS-only session. Kynurenic acid (ionotropic glutamate receptor antagonist; 1.125–4.5 µg/0.5 µl) 
significantly reduced difference scores compared to vehicle (0 µg), whereas MCPG (metabotropic 
glutamate receptor antagonist; 1.875–7.5 µg), AP-5 (NMDA antagonist; 0.03125–2.0 µg), and NBQX 
(AMPA antagonist; 0.5–4.0 µg) had no effects. When AP-5 and NBQX were administered simultaneously 
at doses of 0.25/4.0 and 2.0/4.0 µg, respectively, the combination significantly reduced the difference 
scores compared to 0/0 µg, indicating a reduction in the expression of conditioned approach. These 
findings indicate that either NMDA or AMPA receptor stimulation in the VTA is sufficient, but neither is 
necessary, for the expression of conditioned approach learning to occur.  
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Chapter 1.  
 
 
1. Introduction  
 
A person formerly addicted to crack, getting a sudden craving for the drug by accidentally finding 
the bent spoon where he used to cook the drug; a man passing by an ATM machine and recalling he 
needs to get some money for the weekend; a little girl walking by McDonald’s and unexpectedly “feeling” 
hungry; a group of polar bears in the Arctic watching a particular set of ice blocks waiting for the seals to 
gather around to have some sun. All these scenarios appear very distinct from one another. But in fact, 
they hold something in common very powerful to their core – the neurobiological mechanisms by which at 
one point previously neutral stimuli – the bent spoon, ATM machine, McDonald’s, set of ice blocks – 
became associated with a reward (drug, money, food and food, respectively) expected by the organism in 
each situation. It is within this context that we set the importance of this literature review and discuss in 
more depth the role of glutamate receptor stimulation in reward-related learning. The neurobiology of 
reward-related learning is complex and remains to be fully understood.   
Thus, this dissertation will seek to make a contribution to the body of knowledge pertaining to the 
neurobiological mechanisms involved in reward-related learning and highlight the role of glutamate (Glu) 
receptors in these processes. I will provide a neurobiological background in reward-related learning and 
the importance of this research. This will be followed by a presentation of how Hebb’s learning theory 
influenced our model. Next, a brief description of structural and physiological characteristics of dopamine 
(DA) will be given followed by a more detailed account of the ventral tegmental area (VTA). I will first 
review what is already known about the VTA, specifically the characteristics that make this brain area an 
ideal candidate node where the associative neuronal processes occur, as well as its embedded plasticity, 
in reward-related learning. In particular, I will also address a plethora of structural characteristics of Glu 
receptors – metabotropic glutamate receptors (mGluRs) and ionotropic glutamate receptors (iGluRs) – 
and possible outcomes each kind brings about when implicated in the process of acquiring and 
expressing reward-related learned behaviors. Finally I will detail in specifics the hypothesis and the aims 
of this dissertation. 
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2. Background 
 
2.1. Fundamentals of Reward-Related Learning  
The ability to recognize biologically significant stimuli is one of the most important adaptive 
strategies for survival. A stimulus is a change in the environment that produces a behavioral response. It 
may be an object or an event perceived through an organism's senses. Stimuli may include the sight of 
water, the smell of food, or the smell of a mate. Such stimuli function as rewards. As the organisms learn 
about these rewards’ patterns – when and where they will appear, how they smell, taste and what they 
look like – they develop behaviors that will place them in direct contact with such rewards. In the present 
dissertation, the stimulus/reward will be food and it will serve to bring about an incentive motivational 
effect as food is consumed. Such a stimulus will also be here designated as primary reward – in the 
Pavlovian scheme unconditioned stimulus (US) – for it is (1) crucial for the survival of the species and (2) 
capable of eliciting a response, such as approach, and reinforcing behaviors (Wise, 2004; Wise & 
Rompre, 1989). It should be noted that just because something is labeled as a reward, it does not 
necessarily imply that it is a reinforcer. A reward is an appetitive stimulus given to an organism to alter its 
behavior. Rewards typically serve as reinforcers. A reward stimulus can be defined as a reinforcer only if 
its subsequent delivery as a consequence of the behavior increases the probability of that behavior 
occurring again (Morse & Skinner, 1958; Skinner, 1938).  
  A myriad of studies involving different research paradigms show that one key component of 
reward-related learning is the acquisition of conditioned associations between rewards and stimuli that 
are simultaneously present in the environment. A research model on which environmental cues (e.g., 
stripes on the wall of a chamber) are repeatedly paired with an unconditioned stimulus (e.g., bowl of 
Lucky Charms) is called conditioned place-preference (CPP) only if these environmental cues, over time, 
lead the organism to prefer this side of the chamber as opposed to alternate sides that contained no 
appetitive stimuli associated with it. In CPP the initially neutral environmental cues become associated 
with the motivational properties of the unconditioned stimulus leading to approach toward the 
environment (Bardo, Neisewander, & Miller, 1986; Morency & Beninger, 1986; Spyraki, Fibiger, & Phillips, 
 
 
3 
 
1982). Another model, called conditioned flavor-preferences (CFP), demonstrates that in flavor-flavor 
conditioning, a preference is acquired for an arbitrary flavor cue (e.g., grape flavor) paired with an already 
liked flavor (e.g., sweet flavor of saccharin). In this case, the sweet flavor is considered to be an US that 
reinforces the animal’s preference for the added flavor, which represents the CS (Bodnar, 2004; 
Delamater, Sclafani, & Bodnar, 2000; Sclafani, Bodnar, & Delamater, 1998). In a conditioned approach 
(CA) model, a neutral stimulus (e.g., light) is paired with an US (e.g., food pellet). After a few pairings, the 
light (now CS) will be able to elicit an approach response similar to the one elicited by the food pellet 
itself.  
  These research models exemplify that despite the many different ways to form associations 
between rewards and stimuli the end result highlights a much bigger question – what underlies this 
conditioned activation mechanism; or better yet, once a CS acquires the capacity to act as such, can it be 
disrupted? 
 
2.2. The Importance of This Current Research 
Among the most powerful characteristics of a CS is the capacity that it acquires to control reward 
seeking (further discussed below), in addition to elicit conditioned approach responses similar to the ones 
caused by the primary rewards with which it is associated, thereby leading the organism to approach the 
primary reward. We (Ranaldi, 2014; Zellner & Ranaldi, 2010) and others (Beninger & Ranaldi, 1994; 
Bindra, 1974; Bolles, 1972; Wise, 2004) (Stuber et al., 2008) (Harris & Aston-Jones, 2003) suggest that 
reward-related stimuli become CSs because (1) they gain access to the same motivational neural circuits 
as the primary rewards, thus producing conditioned activation of the same neural pathways activated by 
the US and (2) they are able to elicit motivational states, such as approach behavior, similar to 
motivational states elicited by the primary reward. Exactly how this happens remains to be elucidated.  
Elucidating the neurochemical mechanisms whereby a CS becomes a CS is important because it 
adds insight into understanding reward-related learning pathologies such as addiction. For example, in 
drug addiction, the strength of a CS extends to exerting a significant influence and control over our 
thoughts and our behaviors. Cues previously associated with the drug can trigger drug cravings (Ehrman, 
Robbins, Childress, & O'Brien, 1992; O'Brien, Childress, Ehrman, Robbins, & McLellan, 1992); (Childress 
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et al., 1999) which eventually may lead to drug-seeking (Ranaldi & Roberts, 1996) and subsequent 
relapse (Childress, McLellan, Ehrman, & O'Brien, 1988; Stewart, de Wit, & Eikelboom, 1984; Wallace, 
1989).  Thus, it is important to understand how CSs acquire control of the motivational/approach system. 
This knowledge will enable the identification of neural systems that can be manipulated to eliminate the 
control of CSs over reward-seeking and facilitate the discovery of novel and effective 
pharmacotherapeutic treatments and/or behavioral strategies in the treatment of neurobehavioral 
pathologies such as drug addiction.  
 
2.3. Learning and the “acquired” Relationship Between DA and CS  
The main pillar of the Hebbian learning theory describes a basic mechanism for synaptic plasticity 
where an increase in synaptic efficacy arises from the presynaptic cell’s repeated and persistent 
stimulation of the postsynaptic cell. Furthermore, according to Hebb, simultaneous activation of cells 
leads to pronounced increases in synaptic strength between those cells (Hebb, 1949). Hebb formulated 
what became the basis of the idea of hebbian learning "When an axon of cell A is near enough to excite a 
cell B and repeatedly or persistently takes part in firing it, some growth process or metabolic change 
takes place in one or both cells such that A’s efficiency, as one of the cells firing B, is increased” (Hebb, 
1949). 
 
 
Figure1: A simplified illustration of Hebb’s postulate. Here the graph shows the synaptic efficacy 
increasing over time from cell A after persistent stimulation of cell B. 
  
 
In reward-related learning, reward-associated stimuli acquire the capacity to function as such 
because they gain access to the same motivational neural circuits as primary rewards and become in this 
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way capable of activating these same neural circuits whereby activating DA neurons on their own (Kest, 
Cruz, Chen, Galaj, & Ranaldi, 2012) and elicit motivational states similar to primary rewards (Beninger & 
Ranaldi, 1994; Bindra, 1974; Bolles, 1972; Wise, 2004). We and others suggested that one way whereby 
a CS achieves this is through synaptic plasticity in the VTA (Bonci & Malenka, 1999; Harris, Wimmer, 
Byrne, & Aston-Jones, 2004; Sharf & Ranaldi, 2006; Zellner, Kest, & Ranaldi, 2009).  
 An extensive body of evidence documents a role for DA in the terminal regions of the 
mesocorticolimbic DA system in relation to CSs.  Although this body encompasses several types of 
conditioning I will focus only on that which pertains directly to the conditioned approach type used here.   
In the Pavlovian conditioning context, DA levels in the nucleus accumbens (NAcc) increase in 
relation to the presentation of CSs.  Food-associated CSs increase DA utilization (Blackburn & Phillips, 
1989) and DA release (Bassareo, De Luca, & Di Chiara, 2007; Bassareo & Di Chiara, 1999; Phillips, 
Atkinson, Blackburn, & Blaha, 1993) all in NAcc.  Food deprived animals presented with a palatable meal, 
but prevented from eating it, demonstrate increased NAcc DA concentrations (Wilson, Nomikos, Collu, & 
Fibiger, 1995). CSs associated with cocaine (Kiyatkin & Stein, 1996), morphine or nicotine (Di Chiara & 
Bassareo, 2007) trigger DA release in the NAcc. 
Sub-populations of NAcc neurons change their activity patterns in response to the presentation of 
CSs in a variety of contexts, with predominant changes being excitations.  Although NAcc firing does not 
necessarily indicate VTA activity, it appears that the VTA nevertheless plays a crucial modulatory role in 
NAcc firing in relation to CSs.  Inactivation of the VTA almost completely abolishes cue-evoked firing in 
the NAcc while preserving activity correlated with other task-related events such as an operant response 
and magazine training (Yun, Wakabayashi, Fields, & Nicola, 2004). In primates, a CS signaling of the 
beginning of a food-reward trial excites ventral striatal neurons (Schultz, Apicella, Scarnati, & Ljungberg, 
1992).  Similarly, in humans, presentations of cues predicting delivery or availability of a monetary reward 
activate the NAcc region (Knutson, Fong, Adams, Varner, & Hommer, 2001; Talmi, Seymour, Dayan, & 
Dolan, 2008).  
Together, the evidence of the role of NAcc activity and NAcc DA in responding to CSs is 
extensive, and further shows that in reward-related learning mesocorticolimbic DA activity, initially elicited 
only by USs, can also come to be elicited by CSs.  
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As seen so far, DA plays an important role in the dynamics of reward-related learning. Hence, 
before we discuss what constitutes our neurobiological model of reward-related learning, I will devote the 
next section to DA, its neurochemical and neurophysiological properties. 
 
2.4. Dopamine – an Important Neurotransmitter Underlying Reward-          Related Learning 
Mechanisms 
Dopamine is an organic chemical of the catecholamine and phenethylamine families that is 
critical for the proper functioning of the central and peripheral nervous systems. Its name stems from its 
chemical structure – it is an amine synthesized by removing a carboxyl group from a molecule of its 
precursor chemical L-DOPA, which is synthesized in the brain and kidneys. DA is also synthesized in 
plants and most multicellular animals. In the brain, DA functions as a neurotransmitter performing a 
modulatory role on the cellular level. Neurochemically speaking, DA is one of the catecholamine 
neurotransmitters, and the implicated dopaminergic cell groups project forward from the head of the 
midbrain to several forebrain structures. Subsets of these neurons are also implicated in other aspects of 
motivated behavior, and abnormal functioning of dopaminergic neurons has variously been suggested to 
account for aspects of Parkinson’s disease, schizophrenia, mania and depression. 
DA acts via second-messenger systems to affect slow synaptic transmission (on the order of tens 
of milliseconds to seconds, compared to fast transmission on the order of milliseconds, mediated by Glu 
and GABA [gamma-amino-butyric acid]) (Greengard, 2001). Receptors for DA are grouped primarily 
according to their interaction with cyclic AMP (cAMP) (see Kebabian and Caine, 1979 for review). When 
coupled to the D1 family of DA receptors, DA initiates the activation of cAMP via a Golf activation of 
adenylate cyclase, initiating a cascade of processes which result in phosphorylation of AMPA (α-amino- 
3-hydroxy-5-methyl-4-isoazolepropionic acid) receptors which increase their sensitivity to Glu, making the 
neuron more excitable by several mechanisms, including enhanced surface expression of AMPA and 
NMDA (N-methyl-D-aspartate) receptors (see Surmeier, et al., 2007 for review). On the other hand, when 
bound to the D2 family of receptors, DA usually produces inhibitory effects. D2 receptors couple to Gi/o 
proteins that inhibit adenylate cyclase when activated and have inhibitory downstream effects, including 
decreasing AMPA currents, reducing opening of Na+ channels, and promoting opening of K+ channels 
 
 
7 
 
(Surmeier, 2007). In addition, D1 and D2 receptors are present in different ratios in different brain regions, 
and exist in some areas as autoreceptors as well, leading to opposite effects on DA cells than post-
synaptic neurons.  
In addition to affecting how postsynaptic neurons respond to other input, there is also strong 
evidence of a positive correlation between mesolimbic DA and the expression of learned reward-related 
behavior (Ranaldi, Pocock, Zereik, & Wise, 1999; Richardson & Gratton, 1996; Wightman & Robinson, 
2002). Furthermore, DA plays a crucial role in synaptic plasticity (see Beninger and Miller, 1998; Jay, 
2003 for review). DA binding at the D1 receptors activates adenylate cyclase, increasing the amount of 
cAMP produced, which activates PKA (protein kinase A). PKA phosphorylates AMPA and NMDA 
receptors, as well as phosphorylates CREB (cAMP response element-binding), thereby boosting 
production of various proteins involved in synaptic activity; and DAARP-32, which increases CaMK-II 
(calmodulin-dependent protein kinase II) activity. These events, in conjunction with increased Ca2+ 
currents due to NMDA receptor stimulation, are thought to facilitate synaptic strengthening (Jay, 2003).  
 
2.5. Our Model of Reward-Related Learning 
In our proposed model of synaptic plasticity, one component of reward-related learning is the 
strengthening of CS-related synapses on which neuronal inputs previously associated with neutral 
environmental stimuli have now the capacity to activate VTA DA cells on their own, enhancing DA release 
at the terminal regions (Ranaldi, 2014).  
Initially, the neutral environmental stimulus – we propose a Glu signal – is too weak to efficiently 
activate DA cells and elicit approach behavior.  The consumption of food (US) in a given environment 
releases acetylcholine (ACh) into the VTA, which stimulates muscarinic acetylcholine (mACh) receptors 
on VTA DA cells leading to increased DA in mesocorticolimbic terminal regions (Miller & Blaha, 2005; 
Schilstrom, Svensson, Svensson, & Nomikos, 1998; Westerink, Enrico, Feimann, & De Vries, 1998) 
which stimulates increased approach behavior (Beninger, 1983; Berridge, 2007; Wise & Bozarth, 1987). 
While the VTA DA cells are firing, they are also receiving weak signals from Glu afferents conveying 
information about environmental stimuli. Recent evidence demonstrates that virtually all afferents to the 
VTA comprises some glutamatergic fibers, with the exception of the NAcc and the lateral septum (Geisler, 
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Derst, Veh, & Zahm, 2007), which corroborates earlier anatomical and physiological studies (e.g., 
(Sesack, Deutch, Roth, & Bunney, 1989; Sesack & Pickel, 1992). These afferents lead to Glu stimulation 
of NMDA receptors on VTA DA cells. We presume that this convergence of signals onto the VTA DA cells 
creates the conditions for long-term potentiation (LTP), which is an NMDA receptor dependent 
phenomenon (Bonci & Malenka, 1999; Citri & Malenka, 2007; Stuber et al., 2008), and regarded as one 
of the major intracellular mechanisms of synaptic plasticity underlying the learning process. Moreover, not 
only has it been demonstrated that NMDA receptors are found in the VTA (Rodriguez, Doherty, & Pickel, 
2008) but these synaptic alterations result in Glu being now capable of efficiently activating DA cells 
causing consequently strong DA release. This increased DA release triggered by strengthened CS-
associated synapses in the VTA might result in increased levels of approach behaviors. The 
strengthening of the CS signal may be due to one or more of several NMDA-dependent structural or 
functional synaptic changes such as proliferation of AMPA receptors (Kessels & Malinow, 2009; Nicoll, 
2003), growth of new synapses (Carlisle & Kennedy, 2005), increased presynaptic Glu release (Lisman & 
Raghavachari, 2006) or other processes.  
 It is also proposed that these neuronal changes are responsible for the strengthening of CS-
related synaptic activity on VTA DA cells resulting this way in the acquisition by the reward-related 
stimulus of the capacity to activate VTA DA neurons and elicit conditioned approach. And because the 
VTA receives excitatory inputs from brain structures such as mesopontine cholinergic nuclei – likely 
conveying primary reward signals – and from structures such as superior colliculus, prefrontal cortex 
(PFC) and amygdala (Amyg) – most likely conveying information about environmental stimuli – it is 
feasible to argue that the VTA is an ideal site in which, at least some of these neural associative 
processes arising from this convergent stimulation occur.  
 
2.6. The Primacy of the VTA in Reward-Related Learning Associative Processes  
The VTA, also known as the ventral tegmental area of Tsai (Phillipson, 1979), is a group of 
neurons located close to the midline of mesencephalon. The mammillary bodies and the posterior 
hypothalamus extend rostrally from the VTA. The red nucleus and substantia nigra are situated laterally 
and oculomotor fibers are situated ventromedial to the VTA. The pons and the rhombencephalon lie 
 
 
9 
 
caudally to the VTA. The VTA is the origin of the dopaminergic cell bodies of the mesocorticolimbic DA 
system and is widely implicated in the drug and natural reward circuitry of the brain.  
The VTA projects axons to the medial prefrontal cortex (mPFC); olfactory tubercle and entorhinal 
cortex; Amyg; ventromedial striatum, particularly the NAcc; thalamus; posterior, lateral and preoptic areas 
of hypothalamus; bed nucleus of the stria terminalis; nucleus of the diagonal band; lateral septal nucleus; 
and brainstem areas including several raphe nuclei, parabrachial nucleus, and locus coeruleus 
(Beckstead, Domesick, & Nauta, 1979; Swanson, 1982) (Geisler et al., 2007; Geisler & Zahm, 2005). 
Projections to the PFC and NAcc as well as other structures such as the septum and inferior olive arise 
from separate, non-collateralized populations (Fallon, 1981) (Swanson, 1982) (Fallon, Schmued, Wang, 
Miller, & Banales, 1984). Afferents to the VTA will be reviewed further down in this section.  
The VTA neuronal assemblies are modulated by a myriad of neurotransmitters and peptides, 
including Glu, GABA, serotonin (5-HT), ACh, norepinephrine, opioids, and peptides including CCK 
(cholecystokinin) and orexin (Kalivas, 1993; Meltzer, Christoffersen, & Serpa, 1997) (Mathon, Kamal, 
Smidt, & Ramakers, 2003). The VTA also contains both DA neurons (“principal” cells), which are 
distinguished by long duration action potentials and hyperpolarization to DA but not met-enkephalin, and 
GABA neurons (“secondary” cells), which have short duration spikes and are hyperpolarized by met-
enkephalin but not DA (Johnson & North, 1992a). The GABAergic neurons project both within the VTA 
itself (as interneurons) and outside the VTA (Van Bockstaele & Pickel, 1995). The VTA also contains a 
third kind of cell that remains to be categorized, which does not respond to DA nor opioids (Johnson & 
North, 1992a). Recent research demonstrates the presence of glutamatergic neurons in the VTA, which 
are non-dopaminergic, and non-GABAergic, which may constitute this third type of VTA neuron 
(Yamaguchi, Sheen, & Morales, 2007). It should also be noted that research suggests that Glu is 
released by DA neurons in the NAcc (Chuhma et al., 2004) and PFC (Lavin et al., 2005).  
The VTA receives cholinergic afferents from pedunculopontine (PPTg) and laterodorsal tegmental 
nuclei (LDTg) (Henderson & Sherriff, 1991) (Garzon, Vaughan, Uhl, Kuhar, & Pickel, 1999; Oakman, 
Faris, Kerr, Cozzari, & Hartman, 1995). VTA DA cells possess both mACh receptors and nicotinic 
acetylcholine (nACh) receptors (Gronier & Rasmussen, 1998). Application of ACh or its agonists 
depolarizes VTA neurons in vitro (Lacey, Calabresi, & North, 1990), causes burst firing (Gronier & 
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Rasmussen, 1998; Seutin, Verbanck, Massotte, & Dresse, 1990), DA release in PFC and NAcc (Seutin et 
al., 1990) (Miller & Blaha, 2005; Westerink et al., 1998). Our lab has previously demonstrated that VTA 
nACh receptors are not involved in acquisition nor expression of food-related operant learning (Sharf & 
Ranaldi, 2006), nor in food reward itself (Sharf & Ranaldi, 2006). 
Evidence has shown that VTA ACh is strongly involved in reward-related behavior.  VTA ACh 
concentrations increase during eating, drinking and self-stimulation (Rada, Mark, Yeomans, & Hoebel, 
2000). Stimulation of mACh receptors in VTA enhances brain stimulation reward while mACh receptor 
antagonism reduces it (Kofman & Yeomans, 1988; Yeomans, Kofman, & McFarlane, 1985) (Yeomans, 
Mathur, & Tampakeras, 1993). Furthermore, mACh receptor antagonists in the VTA reduce eating and 
approach behavior (Ikemoto & Panksepp, 1996; Rada et al., 2000). These findings suggest that VTA 
mACh receptor stimulation is involved in mediating the unconditional motivational/approach effects of 
rewards, including food.  Our lab has also shown that intra-VTA microinjections of a mACh receptor 
antagonist prevents the acquisition, but not expression, of food-reinforced instrumental conditioning 
(Sharf, McKelvey, & Ranaldi, 2006), suggesting a necessary role for VTA mACh receptor stimulation in 
reward-related learning. 
The DA neurons of the VTA receive Glu afferents from the mPFC (Sesack & Pickel, 1992; Y. 
Smith, Charara, & Parent, 1996), Amyg nuclei and the bed nucleus of stria terminalis (Hopkins & 
Holstege, 1978; Phillipson, 1979), the PPTg (Charara, Smith, & Parent, 1996), and periaqueductal grey 
area (PAG) (Omelchenko & Sesack, 2009). Glu acts on NMDA, AMPA and mGlu (metabotropic 
glutamate) receptors on DA cells (Albin et al., 1992) to excite these cells (Christoffersen & Meltzer, 1995; 
Overton & Clark, 1992) (J. Zhang, Chiodo, & Freeman, 1994). The NMDA receptor conducts inward 
Ca2+currents, which activate CaMK-II and PKC (protein kinase C), protein kinases linked to gene 
transcription and the proliferation and phosphorylation of AMPA receptors, resulting in LTP of the 
postsynaptic response to Glu.   
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Figure 2: A simplified schematic of the major dopaminergic, glutamatergic and GABAergic connections to 
and from the ventral tegmental area (VTA) and nucleus accumbens (NAcc) in the rodent brain. The 
primary reward circuit includes dopaminergic projections from the VTA to the NAcc, which releases 
dopamine in response to reward-related stimuli. There are also GABAergic projections from the NAcc to 
the VTA; projections through the direct pathway (mediated by D1-type medium spiny neurons (MSNs)) 
directly innervate the VTA, whereas projections through the indirect pathway (mediated by D2-type 
MSNs) innervate the VTA via intervening GABAergic neurons in the ventral pallidum (not shown). The 
NAcc receives dense innervation from glutamatergic monosynaptic circuits from the medial prefrontal 
cortex (mPFC), hippocampus (Hipp) and amygdala (Amyg), as well as other regions. The VTA receives 
such inputs from the lateral dorsal tegmentum (LDTg), lateral habenula (LHb) and lateral hypothalamus 
(LH), as well as both GABAergic and glutamatergic connections from the extended amygdala (not 
shown). The dashed lines indicate internal inhibitory projections. RTMg, rostromedial tegmentum. License 
of the image was granted by Nature Publishing Group for reuse. From The brain reward circuitry in mood 
disorders (Russo & Nestler, Nature Reviews Neuroscience 14, 609-625 (2013)). 
 
VTA Glu, just like VTA ACh, is also implicated in associative learning. Evidence has shown that 
cocaine conditioned locomotion fails to develop under VTA NMDA receptor antagonist treatment (Pert, 
1998). In addition to that, simultaneous antagonism of VTA AMPA and NMDA receptors blocks the 
acquisition of cocaine conditioned place preference (Harris & Aston-Jones, 2003), and VTA NMDA 
receptor antagonism alone blocks acquisition of morphine conditioned place preference (Harris et al., 
2004) and acquisition of conditioned approach (Ranaldi et al., 2011). You et al. (2007) demonstrated that 
context-induced cocaine seeking is positively correlated with VTA Glu release and reduced by intra-VTA 
administration of NMDA or AMPA receptor antagonists, suggesting a role for Glu receptors in the 
maintenance of contextual effects on cocaine-related behavior. Moreover, inhibition of Glu release in the 
VTA during training of heroin self-administration was found to later reduce context-induced reinstatement 
(Bossert, Liu, & Shaham, 2004). Our lab has shown that intra-VTA microinjections of AP-5, an NMDA 
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receptor antagonist, prevents the acquisition, but not expression, of food-reinforced instrumental 
responding (Zellner et al., 2009), and another team (Stuber et al., 2008) has also demonstrated that 
NMDA receptor antagonist can inhibit the acquisition of conditioned approach responses.  
Altogether, this evidence points to the VTA as being a site where at least some of the synaptic 
modifications underlying the ability of previously neutral environmental cues to become associated with 
drug and food reward occur.  
 
3. In Depth – Our Neurobiological Model of Reward-Related Learning  
 
3.1. The Premise  
Our neurobiological model of reward-related learning is predicated on the assumption that 
conditioned approach occurs when the CS acquires the ability to activate the same neural system that 
produces unconditioned approach. We posit that at least some aspects of the neurophysiology underlying 
CS-US associative learning occur in the VTA. A Pavlovian conditioning model may suggest the 
representation of different aspects of a behavioral model in which the US consists of stimulation of mACh 
receptors on VTA DA cells and the CS consists of Glu stimulation of Glu receptors on VTA DA cells. The 
US-associated stimulus becomes a CS through concurrent stimulation of mACh (representing the US) 
and NMDA (representing the eventual CS) receptors on VTA DA neurons. This coincident stimulation 
leads the mACh receptor to strongly depolarize the DA cells, dislodging the Mg2+ ion from the NMDA 
receptor channel allowing this channel to conduct Ca2+ ions into DA cells.  Intracellular Ca2+ initiates the 
CaMKII and PKC intracellular cascades, resulting in several long-term changes that lead to a 
strengthening of the CS signal.  
In our model then, the acquisition of conditioned approach is dependent on both NMDA and 
mACh receptor stimulation, since blockade of either will prevent one or both of the necessary steps 
(NMDA-conductance of Ca2+ and initiation of CaMKII and or PKC) that initiate the neural plasticity for 
long-term change to happen.  Once plasticity has occurred, the previously weak CS-related Glu signal is 
now strong enough to activate DA cells on its own to a level that produces approach behavior. In this 
case, NMDA and/or mACh receptor stimulation are no longer necessary for the expression of this 
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approach behavior, since the performance of this learning appears to be now maintained by whatever 
neuronal changes have resulted in the increased CS signal. In short, our model stipulates that the 
increased strength in CS signal is glutamatergic in nature and that the plasticity of how CS becomes CS 
involves Glu receptors in the VTA.  
             
Figure 3: An illustration of the neurobiological model of reward-related learning in the VTA. Here are 
shown the components of the proposed neural mechanisms necessary for a neutral stimulus the ability to 
acquire the capacity to activate a VTA DA neuron on their own therefore acting as a conditioned stimulus 
that can cause a conditioned approach response. US, mACh receptor stimulation allows for activation of 
VTA DA neurons and then activation of the DA terminal regions that cause approach. CS, NMDA receptor 
stimulation, allows for the conditioned activation of VTA DA neurons and then conditioned activation of 
the DA terminal regions that cause conditioned approach. When there is coincident mACh and NMDA 
receptors stimulation in the VTA DA neurons, calcium flowing through the NMDA receptor initiates 
intracellular cascades resulting in long-term changes in neural activity. It is proposed that these changes 
in neural activity allow CS the ability to acquire the capacity to activate VTA DA neurons on their own and 
elicit conditioned approach. License of the image was granted by De Gruyter for reuse. From Dopamine 
and reward seeking: the role of ventral tegmental area (Ranaldi, Reviews in the Neurosciences 2014; 25 
(5): 621-30. 
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3.2.  From Our Model to Glutamate Focus – Why? 
In recent years, researchers have begun to focus on the neurochemical mechanisms underlying 
reward-related learning finding that many data suggest that DA afferents interact with glutamatergic 
afferents common to the same cell when reward-related learning occurs (Sutton & Beninger, 1999). 
Results from these studies further suggest that a number of signaling molecules activated by Glu and DA 
synaptic transmission interact to convey short and long-term modifications that mediate the 
neurochemical and molecular changes that form the basis of reward-related learning (Sutton & Beninger, 
1999).  
It is this platform of knowledge in the reward-related learning field that guided us to our 
hypothesis – we know that Glu neurotransmission, more specifically NMDA receptor stimulation, is crucial 
for the acquisition of approach learning, but what is it that maintains the approach-learned behavior once 
it is already been learned?    
 Thus, since it appears that glutamatergic neurotransmission is not only involved in acquisition (as 
we will see), but also during the plasticity event and now recently demonstrated (Hachimine 2016) in 
expression of reward-related learning, I will review in the next sections some of the studies focusing on 
glutamate receptors and their implications during acquisition and expression in reward-related learning 
studies. 
 
4. Glutamate – an “Exciting” Way of Transmitting Information in the Brain 
Glu is the major excitatory neurotransmitter in the mammalian central nervous system (CNS) and 
gates cation-permeable ionotropic receptors and activates metabotropic receptors coupled via G proteins 
to activation of phospholipase C (PLC) and inhibition of adenylate cyclase (AC) activity. IGluRs exert the 
rapid neuronal excitation characteristic of glutamate transmission, whereas mGluRs mediate relatively 
slow glutamate responses by coupling to intracellular signal transduction via G proteins (Nakanishi, 
1992). However, glutamate is a common transmitter that acts on both the ionotropic and metabotropic 
receptors with similar efficiency. In what follows, a more detailed structural description and involvement of 
iGluRs and mGluRs in reward-related learning processes will be discussed. 
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4.1. Structure of Ionotropic Glutamate Receptors  
In general, iGluRs are glutamate-gated ion channels that, when activated, increase cationic flux 
(mainly Na+ and K+ ions and to a lesser extent Ca2+ ions) across the neuronal membrane thereby 
increasing cellular excitability (Dingledine, Borges, Bowie, & Traynelis, 1999). There are three major 
types of iGluRs, NMDA containing NR1, NR2A – D and NR3A – B subunits, AMPA containing GluR1 – 4 
subunits, and 2-carboxy-3-carboxymethyl-4-isopropenylpyrrolidine (kainate) receptors containing GluR5 – 
7, KA-1 and KA-2 subunits (Kew & Kemp, 2005; Nakanishi, 1992; Nakanishi & Masu, 1994).  
IGluRs subunits possess an extra-cellular amino terminal domain which shows homology to 
mGluRs bi-lobed agonist binding domain, followed by a first transmembrane domain and then a pore 
forming membrane-residing domain that does not cross the membrane but creates a re-entry loop 
entering from and exiting to the cytoplasm (Kew & Kemp, 2005). The second and third transmembrane 
domains are connected by a large extracellular loop and the third transmembrane domain is followed by 
an intracellular carboxy-terminus (Dingledine et al., 1999; Mayer & Armstrong, 2004). The crystal 
structure of the iGluRs ligand binding domains, which consists of polypeptides in both the amino terminus 
(S1 domain) and the extracellular loop between transmembrane domains 3 and 4 (S2 domain) confirms 
this basic topology model for the iGluR family (Armstrong, Sun, Chen, & Gouaux, 1998; Mayer & 
Armstrong, 2004).  
Even though NMDA and AMPA receptors are found to be under the same category, their basic 
molecular structures strongly differ in complex ways and, pharmacologically speaking, how they interact 
with agonists and antagonist agents (for a comprehensive review on NMDA and AMPA receptor structure 
and pharmacology see Kew & Kemp, 2005) is very distinct from one another. For the purposes of this 
dissertation, I will limit my discussion mostly to NMDA and AMPA receptors in pharmaco-behavioral 
research. 
 
4.1.1. Ionotropic Glutamate Receptors – NMDA and AMPA Receptors – in       
           Reward-Related Learning 
Current research shows that glutamate neurotransmission has been the target of in-depth study 
in reward-related learning mainly because of the interaction between glutamatergic and dopaminergic 
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afferents common to the same cell when reward-related learning is taking place, and the neurochemical 
synergistic effects that they generate. For example, Baldwin et al., 2002 and Smith-Roe & Kelley, 2000 
studies showed that DA D1-like and Glu NMDA receptors produce synergistic effects in the NAcc core 
and mPFC by co-injecting sub-threshold doses of SCH 23390 plus AP-5 and observing that this 
procedure blocked acquisition but not expression of conditioned approach responses in these respective 
sites. 
The exact mechanisms implicated in acquisition or expression of a behavior are not yet fully 
known. It is possible that synergistic effects result from a combination of different antagonists targeting 
different receptors. Co-infusion of low doses of both AP-5 and SCH-23390 into NAcc strongly impaired 
acquisition of lever pressing for food and caused a significant reduction in established responding, 
whereas when infused individually these doses showed no effect (Smith-Roe & Kelley, 2000). Infusion of 
the combined low doses had no effect on parameters of feeding and motor-activity suggesting that this 
specific effect is isolated to learning.  
 Extensive data, including from our lab, show the importance of NMDA receptors in the acquisition 
of conditioned approach. Bilateral injections of AP-5 in the VTA (Ranaldi et al., 2011) and NAcc core (but 
not shell) (Baldwin, Holahan, Sadeghian, & Kelley, 2000; Di Ciano, Cardinal, Cowell, Little, & Everitt, 
2001; Kelley, Smith-Roe, & Holahan, 1997) blocked acquisition, but not expression, of approach 
behavior, whereas injections of AP-5 into the dorsal or ventral subiculum were without effect (Baldwin et 
al., 2000). Interesting to note, Di Ciano and colleagues (2001), using a discriminated approach to a lever 
that was extended to signal the delivery of a food pellet, further demonstrated that intra-NAcc core 
injections of LY293558 (AMPA receptor antagonist) did not block acquisition of approach behavior but 
impaired discrimination, so that approach was seen to levers that signaled either food or no food. The 
findings of this study suggest that NMDA receptors are implicated in the NAcc core, BLA and mPFC in 
the acquisition but not expression of conditioned approach responses. Furthermore, on a side note, it also 
demonstrates that AMPA receptors may play an important role in discriminative learning.  
We (Zellner et al., 2009) and others (Kelley et al., 1997) further demonstrated that NMDA 
receptors are also important for the acquisition of lever pressing for food in rats. Intra-VTA injections of 
AP-5 impaired acquisition of lever pressing for food during learning sessions, whereas expression of 
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performance remained unaffected. Since AP-5 failed to reduce free feeding, food reward or motor activity, 
the observed impairment in acquisition cannot be attributed to reduced food motivation or locomotor 
activity (Zellner et al., 2009). Similar results were found when AP-5 was injected in the NAcc core and in 
the NAcc shell. Blockade of NMDA receptors in both regions abolished lever-press acquisition but not 
performance of operant responding (Kelley et al., 1997). Baldwin et al. (2000) also reported similar effects 
observing that not only was learning impaired by injections of AP-5 into NAcc core, but learning was also 
impaired by injections of AP-5 into BLA (basolateral Amygdala) or mPFC but not into dorsal or ventral 
subiculum on lever pressing acquisition. Taken together, these findings suggest that NMDA receptors are 
crucial for acquisition but not performance of learning. 
The previous conclusion led research to alternatively investigate the role of AMPA receptors in 
the expression of lever pressing. For example, Pierce and colleagues (1997) demonstrated that MK-801, 
an NMDA receptor antagonist, decreased responding for cocaine but had no effect on responding for 
food, and that DNQX (AMPA receptor antagonist) similarly attenuated responding for cocaine and food. 
These findings indicate that NMDA receptors are implicated in the expression of lever press responding 
for cocaine but not food whereas AMPA receptors appear to be involved in the expression of both 
reinforcers. Moreover, blockade of AMPA receptors by infusion of CNQX (an AMPA receptor antagonist) 
into the NAcc abolished both reinstatement of lever pressing by cocaine priming (Cornish & Kalivas, 
2000) and reinstatement of cocaine seeking induced by intra-mPFC cocaine (W. K. Park et al., 2002) 
demonstrating that the activation of AMPA receptors in the NAcc appears to be essential for the 
expression of drug craving induced by cocaine. 
Accumulating evidence shows that ionotropic glutamatergic activation appears to be also critical 
in reward-related learning that involve drugs of abuse. Blockade of iGlu receptors in the VTA has been 
shown to dose-dependently decrease cocaine-primed reinstatement (Sun, Akins, Mattingly, & Rebec, 
2005), attenuate cocaine-context mediated responding (You, Wang, Zitzman, Azari, & Wise, 2007) and 
impair acquisition and expression of CPP with amphetamine (Bespalov, 1996). Furthermore, Koob et al. 
(1992) demonstrated that injections of AP-5 into the NAcc produced an increase in cocaine (but not 
heroin) self-administration suggesting a decrease in cocaine reward (Pulvirenti, Maldonado-Lopez, & 
Koob, 1992). This data contrasts with other studies that show that systemic administration of Glu NMDA 
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receptor antagonists such as MK-801 augmented reward produced by cocaine (Pierce, Meil, & Kalivas, 
1997; Ranaldi, French, & Roberts, 1996; Shoaib, Shippenberg, Goldberg, & Schindler, 1995). Interesting 
to note, MK-801 was also found to impair acquisition of cocaine self-administration. Schenk et al. (1993) 
reported that rats treated with MK-801 pressed both the active and inactive lever indiscriminately even 
after discontinuation of the administration of the antagonist. (Schenk, Valadez, McNamara, et al., 1993) 
(Schenk, Valadez, Worley, & McNamara, 1993). Recently, it has also been suggested that blockade of 
iGluRs in the VTA hindered the rat’s preference to the environment associated with cocaine. (Harris & 
Aston-Jones, 2003). 
Research has indicated that iGluRs also interferes with the conveyance of the rewarding effects 
of opioids. For example, blockade of ionotropic glutamatergic transmission in the VTA reduces heroin 
reinforcement in rats (Xi & Stein, 2002) and AP-5 injections in the NAcc decreased ethanol reward 
(Rassnick, Pulvirenti, & Koob, 1992). Altogether, these findings suggest that iGluRs in the 
mesocorticolimbic region may also play an essential role in modulating opiate reinforcement. 
Collectively, research appears to further favor the conclusion that ionotropic glutamatergic 
neurotransmission plays an essential role in the process of acquisition and expression of reward-related 
learning. More specifically, NMDA receptors are crucial for acquisition whereas AMPA receptors appear 
to be less important for acquisition than for expression of such learning processes. Further investigations 
into the role of NMDA and AMPA receptors in the brain regions that innervate the VTA will enhance our 
understanding of the neural substrates underlying the mechanisms of reward-related learning.  
 
4.2. Structure of Metabotropic Glutamate Receptors 
In 1985 Glu was reported to stimulate PLC in cultured striatal neurons via a receptor that did not 
belong to the NMDA, AMPA or KA (kainate) receptor families (Pin & Duvoisin, 1995; Sladeczek, Pin, 
Recasens, Bockaert, & Weiss, 1985). Soon after, a similar effect of Glu was described in hippocampal 
slices (Nicoletti, Wroblewski, Iadarola, & Costa, 1986) and cultured cerebellar granule cells (Nicoletti, 
Wroblewski, Novelli, Guidotti, & Costa, 1986). These results suggested that Glu, like GABA, 5-HT and 
ACh, not only activated ligand-gated channel receptors but also receptors coupled to GTP-binding 
proteins (G-proteins). This novelty was then called mGluRs and it was confirmed using the Xenopus 
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oocytes model (Kaneko, Kato, Yamagishi, Sugiyama, & Nomura, 1987; Nomura, Kaneko, Kato, 
Yamagishi, & Sugiyama, 1987). To date, eight members of the G-protein-coupled mGluR family have 
been identified (mGluR1-8) which have been divided on the basis of sequence homology, second 
messenger coupling and pharmacology into three groups: group I (mGluR1 and 5), group II (mGluR2 and 
3) and group III (mGluR4, 6, 7, 8) (Pin & Duvoisin, 1995; Tanabe, Masu, Ishii, Shigemoto, & Nakanishi, 
1992) (Kew & Kemp, 2005). Group I mGluRs predominantly couple via Gq/G11 to phospholipase C, 
whereas the group II and group III receptors couple via Gi/Go to inhibition of adenylyl cyclase activity. 
Although mGluR family members can mediate synaptic transmission via activation of slow excitatory 
postsynaptic potentials, they generally exert a more modulatory role, regulating neuronal excitability, 
synaptic transmission and plasticity. MGluR-mediated signaling is achieved both via the activation of 
intracellular second messenger pathways and subsequent regulation of downstream effectors and 
through the direct action of the βγ subunits of the heterotrimeric G protein, e.g., in the modulation of ion 
channel activity (Anwyl, 1999). With the exception of mGluR6 which is confined to the retina (Nakajima et 
al., 1993) all of the mGluR family members are expressed in the mammalian CNS in both neuronal and 
glial cells, with individual family members exhibiting distinct spatial and temporal expression profiles (Li et 
al., 2000) (Thomas et al., 2001).  
MGluR family members all possess a large bi-lobed extra-cellular N-terminal domain, which has 
been demonstrated by site-directed mutagenesis (Malherbe et al., 2001) (Sato, Shimada, Nagasawa, 
Nakanishi, & Jingami, 2003) to contain the Glu binding site. The N-terminal bi-lobed domain is linked via 
an extracellular cysteine-rich region to a typical GPCR (G-protein coupled receptor) transmembrane 
heptahelical domain, which mediates G protein activation (Bhave et al., 2003; Galvez & Pin, 2003). The 
C-terminus is intracellular and plays an important role in the regulation of receptor activity and targeting 
through an interaction with proteins including calmodulin (Galvez & Pin, 2003). 
Functional mGluRs are thought to comprise homodimers stabilized by both an intersubunit 
disulphide bond and hydrophobic interactions (Kunishima et al., 2000; Romano, van den Pol, & O'Malley, 
1996) (Tsuchiya, Kunishima, Kamiya, Jingami, & Morikawa, 2002). In the absence of ligands or when 
occupied by competitive antagonists, the bi-lobed extracellular domains of the homodimer exist physically 
separated in an open conformation. Upon agonist binding they adopt a closed conformation, and move 
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together into direct contact. Rotation of the extracellular domains of the receptor dimer relative to each 
other is thought to trigger intracellular signal transduction by stabilizing the two transmembrane 
heptahelical domains in an active conformation (Kunishima et al., 2000) (Tsuchiya et al., 2002). Research 
has demonstrated that Ca2+ sensing receptor, isolated from a bovine parathyroid cDNA library, has been 
found to have about 30% sequence identity with mGluRs (Fujisawa et al., 1993). This receptor is also 
sensitive to Mg2+ and it is possible that there exist additional ion-sensitive receptors related to mGluRs. 
This scenario leads the way for future directions in a more in depth mGlu receptors molecular research. 
 
4.2.1. Metabotropic Glutamate Receptors in reward-related learning 
Since the development of (+) α-methyl-4-carboxyphenylglycine (MCPG) as a new competitive 
antagonist for mGluRs (Eaton et al., 1993), an extensive number of studies have examined the 
implications of mGluRs in the induction of LTP in the hippocampus and only a few were conducted in the 
midbrain. Collingridge and his colleagues first reported that MCPG blocked the induction of both NMDA 
receptor-dependent LTP at the CA1 region and NMDA receptor-independent LTP at the CA3 region in rat 
slice preparations (Bashir, Bortolotto, et al., 1993; Bashir, Jane, Sunter, Watkins, & Collingridge, 1993). 
Not only the same conclusion of the blocking effect of MCPG on the induction of LTP was reported by two 
other laboratories (Riedel & Reymann, 1993) (Richter-Levin, Errington, Maegawa, & Bliss, 1994), but 
Riedel et al. (1994) and Richter-Levin et al. (1994) also observed that MCPG disrupts spatial learning in a 
water maze task and a Y-maze task, both of which involve hippocampal-dependent learning. 
Furthermore, in contrast to Bashir et al. (1993) findings that MCPG antagonized both the mGluR-
mediated blocking effect of ACPD (selective mGluR receptor agonist) on the slow AHP (after hyper-
polarization) in hippocampal pyramidal cells – CA1 region – and the mGluR-mediated presynaptic 
inhibitory effect on EPSPs (excitatory post-synaptic potentials) in the CA1 and CA3 regions, Manzoni et 
al. (1994) reported that this antagonist was without effect on LTP in both the CA1 and CA3 regions. 
Chinestra et al. (1993) observed that MCPG neither prevented the induction of LTP nor antagonized the 
above mGluR actions in the CA1 region. These conflicting findings among different laboratories remain to 
be resolved. Collingridge and his colleagues extended their observation and showed that the role of 
mGluRs in LTP induction is different from that of NMDA receptors (Bortolotto, Bashir, Davies, & 
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Collingridge, 1994) and that MCPG reversibly blocked the induction of LTP in naive slices but failed to 
prevent the subsequent induction of LTP after LTP had already once been initiated. 
Most information accrued regarding glutamatergic involvement in behavioral activation involves 
mostly ionotropic glutamate receptors (Burns, Everitt, Kelley, & Robbins, 1994; Pap & Bradberry, 1995; 
Pulvirenti & Koob, 1994). Thus, relatively few studies have evaluated the role of mGluRs in the 
mesoaccumbens projection to modulate motor activity. For example, Swanson and Kalivas (2000) 
showed in an intracranial bilateral cannulae microinjections study that Group I and Group II mGluR 
stimulation in the VTA and NAcc elicits motor activation. Kim and Vezina (1998) showed that rats pre-
exposed to AMPH (amphetamine) in the VTA showed significantly higher locomotor activity when 
subsequently tested with a systemic AMPH challenge than rats pre-exposed to VTA saline. Rats pre-
exposed to AMPH but co-injected with the selective mGluR antagonist RS-MCPG did not show this effect. 
These findings demonstrate that activation of mGluRs in the VTA is crucial for the induction of locomotor 
sensitization to amphetamine and further demonstrate the importance of excitatory amino acids in the 
VTA in the development of sensitization to amphetamine.  
Even though all of the above studies were based on experiments using MCPG, it is noteworthy to 
mention that MCPG is a relatively weak antagonist and also reacts with different subtypes of mGluRs 
(Hayashi et al., 1994). Because circumstantial evidence has supported the involvement of mGluRs in the 
induction of LTP (Zheng & Gallagher, 1992) (Bortolotto et al., 1994) (Bortolotto & Collingridge, 1993) 
different approaches are also necessary to investigate the role and mechanisms of mGluRs in the 
induction of LTP and consequently reward-related learning. The exact mechanisms involved in LTP 
induction or potentiation by mGluRs are not known. Although the activation of PKC and the resulting 
potentiation of NMDA responses (O'Connor, Rowan, & Anwyl, 1994) may explain the facilitatory role 
played by mGluRs in the NMDA-mediated induction of LTP (M. A. Musgrave, Ballyk, & Goh, 1993), this 
action may not be enough for a pure mGluR –mediated induction of LTP. It is possible that an increase in 
cAMP induced by mGluRs may also be involved in this mechanism (Gereau & Conn, 1994; I. F. 
Musgrave, Genieser, Maronde, & Seifert, 1993).  
MGluRs have been found to play an important role in regulating intra-cranial self-stimulation 
behavior in the VTA (Taber, Das, & Fibiger, 1995) (Kenny, Gasparini, & Markou, 2003; Meller, Harrison, & 
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Sharp, 2002). In addition to that, investigations have begun to elucidate the role of mGluRs in regulating 
drug use and abuse. Particularly, there appears to be an increased interest in the role of mGlu5 receptors 
based on the observations that mice in which the deleted gene encoding for the mGlu5 receptor did not 
acquire cocaine self-administration behavior (Chiamulera et al., 2001). Interestingly, responding for food 
under a similar schedule of reinforcement was not affected in these same mice (Chiamulera et al., 2001) 
demonstrating that the lack of responding for cocaine was not secondary to a deficit in learning or motor 
processes. Additional studies show that MPEP – an mGlu5 receptor antagonist – decreased cocaine self-
administration in rats (Kenny et al., 2003) and nicotine self-administration in rats and mice (Kenny et al., 
2003). Moreover, activation of mGluRs during pre-exposure to AMPH in the VTA appears to be essential 
for the enhancement of cocaine self-administration to develop (Kim & Vezina, 1998). 
A large body of research also shows that alterations in glutamate-mediated transmission might be 
the driving force in relapse to drug-seeking behavior (Sutton et al., 2003; Vorel, Liu, Hayes, Spector, & 
Gardner, 2001). By the same token, but in the opposite direction, activation of Group II mGluRs in the 
NAcc shell has been shown to attenuate context-induced relapse to heroin seeking (Bossert, Gray, Lu, & 
Shaham, 2006). Bossert and colleagues (2004) also found, using a rat relapse model, that exposure to 
the heroin-associated context induced robust reinstatement of drug seeking and this effect was 
attenuated by systemic or intra-VTA injections of LY379268 – an mGlu2/3 receptor agonist. Moreover, 
Liechti and colleagues further demonstrated that acute systemic and intra-VTA or intra-accumbens 
application of the very same agonist decreased nicotine, but not food, self-administration in rats, and 
decreased both cue-induced reinstatement of nicotine and food-seeking behavior in rats (Liechti, Lhuillier, 
Kaupmann, & Markou, 2007).  
Taken together, research seems to be further corroborating that glutamate transmission in the 
VTA plays a critical role in the mediation of the rewarding effects of not only drugs of abuse, but also in 
food reward context. 
 
5. Overview of Specific Aims 
This dissertation was designed to test a hypothesis arising from a model of reward-related 
learning which proposes that synaptic plasticity in the VTA constitutes at least one component underlying 
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the ability of conditioned stimuli to activate motivational circuits. This model proposes that glutamate 
synapses receiving signals associated with previously neutral stimuli become strengthened due to 
coincident excitation of VTA DA cells by cholinergic afferents transmitting a primary reward signal. This 
synaptic strengthening is mediated by NMDA receptors, whose ion channels are opened in the presence 
of depolarization, allowing for calcium influx that triggers second-messenger cascades leading to an 
increased excitability at those synapses, supposedly because of increased sensitivity of existing AMPA 
receptors or increased trafficking of AMPA receptors into the post-synaptic membrane. As these 
glutamate synapses are strengthened, glutamate signals associated with environmental signals begin to 
acquire the ability to activate VTA DA cells on their own, leading to an increase in approach behaviors, 
and thereby facilitating encounters with stimuli associated with reward.  
Furthermore, this model stipulates that NMDA receptor stimulation is critical for the induction of 
this synaptic strengthening, in other words the acquisition of these conditioned associations, but that, 
once LTP has occurred, NMDA receptor stimulation, at least alone, is not important for the maintenance 
of VTA LTP – expression of reward-related associations. The latter appears to be, at least in part, 
dependent on AMPA receptor stimulation.  
Because less is known about the neural mechanisms involved in the maintenance of an already 
learned behavior, it seems plausible that the maintenance of conditioned approach may be mediated by 
glutamate neurotransmission. Accordingly, this dissertation tested the hypothesis that blockade of one or 
more of NMDA, AMPA and mGlu receptors in the VTA impairs the expression of food-based conditioned 
approach learning.  
Thus, the first specific aim of this dissertation was to assess if any kind of glutamate receptor 
stimulation in the VTA is crucial for a food-associated stimulus (CS) to elicit conditioned approach. 
For specific aim 1, a paradigm was designed in which rats would be prepared with indwelling 
cannulae positioned so as to allow bilateral microinjections of kynurenic acid – (a non-selective ionotropic 
Glu R antagonist) – in the VTA. Male rats would be trained for seven consecutive sessions to retrieve a 
food pellet following a light presentation (the CS, a 3-s discrete light immediately preceding the US 
delivery) and have their head entries before, during and after the CS measured. After that a subsequent 
extinction session in which neither the CS nor pellets were presented, a final (test) session was 
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conducted in which rats would be tested for the expression of the food trough approach response with 
only CS presentations. Again, head entries before, during and after the CS were measured. Rats would 
receive bilateral injections of kynurenic acid immediately prior to the CS-only test session. Subsequently, 
all rats’ brains would then be removed and processed for cannulae verification. If the number of CS minus 
pre-CS head entries for any kynurenic acid group did show a significant decrease during the test session 
in comparison with CS minus pre-CS head entries for rats receiving vehicle treatment, and, as expected, 
it did, this would indicate an impairment in the expression of conditioned approach. This would further 
corroborate that Glu receptor stimulation in the VTA is crucial for a food-associated stimulus (CS) to elicit 
conditioned approach. 
The second specific aim of this dissertation is based upon the confirmation of our hypothesis 
delineated in specific aim 1.  We predicted, in keeping with our hypothesis, that intra-VTA application of 
kynurenic acid would impair reward-related learning and thus rats would show significant decrease in 
conditioned approach responses when contrasted with vehicle rats. Hence, for specific aim 2, our role 
was to further investigate which subtype of Glu receptors in the VTA could be responsible for the 
impairment of the expression of this learned approach. For that we would use selective metabotropic and 
selective ionotropic Glu Rs antagonists  (MCPG; AP-5 and NBQX, respectively) to test which specifically 
Glu Rs play an important role in the expression of conditioned approach.  
For specific aim 2 the methodology is identical to the one delineated in specific aim 1 except that 
rats would receive bilateral injections of either MCPG, AP-5, NBQX or a combination of both types of 
ionotropic Glu Rs antagonists compounds immediately prior to the CS-only test session. And if the 
number of learned approach responses for any of these specific GluR antagonist groups was significantly 
smaller on the test session in comparison with the conditioned approach responses for rats receiving 
vehicle treatment, and, as expected, it was, this would presumably indicate which are the Glu receptors 
responsible for the significant impairment in the expression of conditioned approach response.  
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Chapter 2.  
 
 
 
2. Methodology 
The protocols used in the present experiments were in accordance with the National Institutes of 
Health Guide for Care and Use of Laboratory Animals and were approved by the Queens College 
Institutional Animal Care and Use Committee.  This chapter describes procedures that were used for all 
experiments described in this dissertation.   
 
2.1. Subjects 
 
 Subjects consisted of 178 male Long Evans rats, facility-bred from males and females obtained 
from Charles River Laboratories (Raleigh, NC), with initial free feeding weights between 350 and 375 g at 
the time of surgery. All rats were individually housed and maintained on a 12 h light: 12 h dark cycle 
(lights off at 6AM). All experimental sessions were conducted during the dark phase in order to test the 
rats during their active periods. All animals had unlimited access to food (LabDiet chow) until 
experimental sessions began, at which time access was restricted to daily rations that maintained their 
weights at 85% of their free-feeding values. 
 
2.2. Surgical procedure   
All animals received an intraperitoneal (IP) injection of atropine sulfate (0.1 ml) and were 
anesthetized with sodium pentobarbital (65 mg/kg). Stainless steel guide cannulae (0.635 mm outer 
diameter, 0.3302 mm inner diameter) were bilaterally implanted to a depth that allowed for microinjections 
into the ventral tegmental area (VTA) using the following coordinates: −5.6 mm caudal to bregma, ±2.0 
mm from the midline at a 10 º angle toward the midline and −8.4 mm below the surface of the skull. The 
cannulae were fixed in dental acrylic anchored to the skull by four stainless steel screws. Obturators 
(0.3048 mm diameter) were inserted at all times except during microinjections. 
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2.3. Experimental and testing apparatus 
 
All behavioral testing was conducted in eight conditioning chambers each measuring 30 cm × 21 
cm ×18 cm (l × w × h). One wall was equipped with a food trough and two white light stimuli, each 
situated 2.54 cm above and 2.54 cm to the right or left of the food trough. Each food trough was equipped 
with a photo-emitter and detector to detect head entries.  Each chamber was housed in a ventilated, 
sound attenuating box. The chambers were controlled by a PC through a MED Associates interface. 
 
2.4. Conditioning experiments 
 Four to seven days after surgery animals began the food restriction diet to reduce their weights to 
85% of their free-feeding values where they were maintained for the duration of the experiments. For 
three consecutive days prior to the magazine training session all rats were given 20 food pellets (45 mg, 
Purified Formula, Bioserv, Frenchtown, NJ) in a bowl in their home cages.  
 
2.5. Conditioning procedure  
 
Subjects were given one 20-min magazine training session in the conditioning chambers in which 
20 food pellets were delivered on a random time schedule, to allow rats to become acquainted with 
magazine delivery of food pellets. After that, the animals were exposed to 7 conditioning sessions, held 
one per day, consecutively.  During each conditioning session 30 food pellets were delivered on a 
random time 120-s schedule. Each pellet delivery was preceded by a 3-s presentation of a light on the left 
side of the trough. One day following these sessions, all rats received one 30-min session during which 
no light or food presentations were made. This session occurred (1) in an attempt to bring all animals’ 
responses to the same level; and (2) to prevent a new experience of no food associated with light in the 
conditioning chambers prior to the test session. The next day was the CS-only test, a 60-min session in 
which only light presentations were made according to the same random time schedule as in the 
conditioning sessions and no food pellet deliveries occurred (see Figure 3).  Just prior to the CS-only test 
session, all rats received intra-VTA vehicle or one of the glutamate receptor antagonist microinjections. 
For all rats the number of head entries during each session was counted and analyzed (see section 2.9 
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below for details). After the CS-only test session the animals were killed and their brains were extracted 
and prepared for histological cannula placement verification.  
7 days surgery recovery                   DAYS 
Figure 4: Summary of the main points elaborated in the text. During the seven days of one hour 
sessions, the environmental stimulus (light) was paired with the unconditioned stimulus (food pellet). On 
the last day – test session – the expression of the previously learned approach was measured.  
 
2.6. Microinjection procedure 
 
Immediately prior to the CS-only test session both obturators were removed from the guide 
cannulae and a stainless steel injector tube was inserted in each side to extend 1 mm beyond the end of 
each guide cannula. Each injector was connected by polyethylene tubing to a 10 µl Hamilton syringe 
(Reno, NV) preloaded with one of the glutamate receptor antagonists (kynurenic acid, MCPG, AP-5, 
NBQX, AP-5/NBQX combination) or its respective vehicle. The compound was injected using a pump 
(Harvard Apparatus) over a 90-s period. Each injector was kept in place for an additional 60 s before 
being removed and the obturator replaced. Next, the animals were placed in their respective conditioning 
chambers and the test sessions started. 
 
2.7. Drugs  
All drugs were purchased from Sigma–Aldrich, St. Louis, MO. For all drugs, each microinjection 
was delivered in a volume of 0.5 µl.  Kynurenic acid (ionotropic glutamate receptor antagonist) was 
dissolved in NaOH and the doses used were 0.28125, 1.125 and 4.5 µg. MCPG (metabotropic glutamate 
receptor antagonist) was dissolved in DMSO and the doses used were 1.875, 3.75 and 7.5 µg. AP-5 
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(NMDA receptor antagonist), NBQX (AMPA receptor antagonist) and AP-5/NBQX combination were all 
dissolved in 0.9% saline. The doses of each of these latter compounds were 0.03125, 0.5, 1.0, 2.0 µg; 
0.5, 1.0, 2.0, 4.0 µg; and 0.03125/4.0, 0.25/4.0, 2.0/4.0 µg, respectively.  The doses of these compounds 
were chosen based on effective dose ranges observed in the literature. 
 
2.8. Histology 
 
Immediately after the end of the last session rats were anesthetized with an overdose of sodium 
pentobarbital, perfused with 0.9% saline followed by 4% formalin, and decapitated. The brains were 
removed and stored in 4% formalin for at least seven days before being sectioned in the coronal plane on 
a cryostat and inspected for cannulae implantations and injection sites. All rats included in the data 
analysis had verified cannulae placements in VTA.   
   
2.9. Data analysis 
The data consisted of the number of food trough head entries made during (1) the 6-s periods 
immediately preceding the onset of the CSs (pre-CS period), (2) the 6-s periods commencing with the 
onset of the CSs, (3) at all other times (non-CS period). For each session the total number of head entries 
during the CS periods and the total number of head entries during the pre-CS periods were used to 
calculate the difference scores between CS and pre-CS head entries. This difference score directly 
indicates the magnitude of the conditioned approach response (i.e., the degree to which food trough head 
entries were elicited by the CS).  Separate one-way ANOVAs with dose as a between groups factor and 
session as a repeated measures factor were conducted on the total number of head entries data from 
sessions 1 to 7 for each test compound. Significant interactions were followed by tests of simple effect of 
session at each dose. Separate one-way ANOVAs were conducted on the difference scores (CS minus 
pre-CS food trough head entries) during the CS-only test session. Significant effects were followed by 
Tukey’s post hoc tests. 
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3. Results 
 
3.1. Histology 
 
Only the data from rats with verified VTA cannula placements were included in these results. The 
majority of microinjection sites were localized in the caudal portion of the VTA (-5.6 to -6.04 mm posterior 
to bregma) with some injections occurring in the central portion of the VTA (-5.2 to -5.3 mm posterior to 
bregma) (see Figure 4). 
 
Although during conditioning all groups received no treatments prior to the sessions, the data 
were divided according to the treatment that they would receive in the CS-only test session and analyzed.  
All groups showed similar patterns of increasing difference scores across early conditioning days and 
remaining stable during the last few conditioning days. Statistical analyses showed that there were no 
significant differences among groups.  
 
3.2. Effects of intra-VTA kynurenic acid on expression of conditioned approach 
 
Figure 5 shows the difference score between CS and pre-CS food trough head entries in the CS-
only test session after groups received vehicle or a dose of kynurenic acid. The 1.125 and 4.5 µg groups 
showed smaller difference scores than the 0.28125 µg and vehicle groups. A one-way ANOVA revealed a 
significant dose effect [F (3, 25) = 6.06, p < .01)]. Tukey’s post hoc comparisons revealed that the animals 
receiving 1.125 or 4.5 µg kynurenic acid showed significantly smaller difference scores compared to 
animals receiving vehicle (p < .01). Figure 6 shows that all groups made similar amounts of total head 
entries during the CS-only test session except for the 4.5 µg kynurenic acid group which made a greater 
number of total head entries.  A one-way ANOVA revealed a significant dose effect [F (3, 25) = 4.358, p < 
.05] and Tukey’s post hoc tests showed that the 4.5 µg group was significantly different from the 0.28125 
and 1.125 µg groups.  
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3.3. Effects of intra-VTA MCPG on expression of conditioned approach 
 
In Figure 7, CS minus pre-CS food trough head entries in the CS-only test session are shown 
after groups receiving vehicle or a dose of MCPG. All groups showed similar difference scores when 
compared to vehicle. Statistical analyses supported this observation with a one-way ANOVA failing to 
reveal a significant dose effect. Figure 8 shows that during the CS-only test session rats receiving 1.875 
µg MCPG made fewer total head entries than the groups receiving vehicle, 3.75 µg or 7.5 µg MCPG.  A 
one-way ANOVA revealed a significant dose effect [F (3, 28) = 6.798, p < .01]. Tukey’s post hoc 
comparisons among MCPG doses revealed that the animals receiving 1.875 µg MCPG made significantly 
fewer total food trough head entries compared to animals receiving vehicle, 3.75 or 7.5 µg MCPG (p < 
.01).  
 
3.4. Effects of intra-VTA AP-5 on expression of conditioned approach 
 
Figure 9 shows the difference score during the CS-only test session in rats receiving vehicle or a 
dose of AP-5. Although rats receiving AP-5 tended to show higher difference scores than the vehicle 
group the differences were not significant. In Figure 10, the CS-only test session shows that all groups 
receiving AP-5 appeared to make more total food trough head entries than the vehicle group but a one-
way ANOVA failed to reveal a significant dose effect.  
 
3.5. Effects of intra-VTA NBQX on expression of conditioned approach 
 
Figure 11 shows the difference scores in the CS-only test session after groups received vehicle 
or a dose of NBQX. All groups demonstrated similar difference scores when compared to vehicle. 
Statistical analyses supported these observations with a one-way ANOVA failing to reveal a significant 
dose effect. In the CS-only test session, all groups appeared to make similar amounts of total head 
entries (Figure 12). A one-way ANOVA revealed a significant dose effect [F (4, 36) = 2.640, P < .05] but 
Tukey’s post-hoc comparisons failed to reveal significant differences among doses.  
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3.6. Effects of intra-VTA AP-5/NBQX combinations on expression of conditioned approach 
 
Figure 13 shows the difference scores between CS and pre-CS food trough head entries in the 
CS-only test session after groups received vehicle or AP-5 alone or AP-5 combined with NBQX. Groups 
receiving the AP-5/NBQX combinations demonstrated a dose-related reduction in the difference score 
compared to vehicle.  A one-way ANOVA on these data revealed a significant dose effect [F (4, 39) = 
4.543, p < .001]. Tukey’s post-hoc tests confirmed that 0.25 AP-5/4.0 µg NBQX and 2.0 AP-5/4.0 µg 
NBQX had significantly smaller difference scores than vehicle and AP-5-alone. Parallel to it, the group 
receiving 0.03125 AP-5/4.0 µg NBQX made a greater number of total head entries than all the other 
groups (Figure 14). A one-way ANOVA on these data revealed a significant dose effect [F (4, 39) = 4. 
035, p < .01]. Tukey’s post-hoc tests indicated that the 0.03125 AP-5/4.0 µg NBQX group emitted a 
significantly greater number of total head entries in the CS-only test session compared to vehicle, p < 
0.05. No significant difference was found between the vehicle group and four subjects under 2.0 AP-5/4.0 
µg NBQX group whose site of injection “missed” the VTA (data not shown).   
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Figure 5: Histological reconstruction of injection sites adapted from Paxinos and Watson (Paxinos & 
Watson, 1982). Black circles represent intra-VTA injections. The numbers to the right of each section 
indicates the distance posterior to bregma. 
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Figure 6: Mean (±SEM) CS minus pre-CS difference scores for groups receiving no treatment prior to 
each conditioning session and kynurenic acid prior to the CS-only session. ♦ represents significant 
increase across the seven conditioning sessions. The arrows represent significant differences from the 
vehicle group, p < 0.01. kyn is kynurenic acid. 
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Figure 7: Mean (±SEM) total number of food trough head entries emitted during the seven conditioning 
and the CS-only sessions for groups receiving no treatment prior to each conditioning session and 
kynurenic acid prior to the CS-only session.  
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Figure 8: Mean (±SEM) CS minus pre-CS difference scores for groups receiving no treatment prior to 
each conditioning session and MCPG prior to the CS-only session. ♦ represents significant increase 
across the seven conditioning sessions. 
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Figure 9: Mean (±SEM) total number of food trough head entries emitted during the seven conditioning 
and the CS-only sessions for groups receiving no treatment prior to each conditioning session and MCPG 
prior to the CS-only session. (B)  
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Figure 10: Mean (±SEM) CS minus pre-CS difference scores for groups receiving no treatment prior to 
each conditioning session and AP-5 prior to the CS-only session. ♦ represents significant increase across 
the seven conditioning sessions. 
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Figure 11: Mean (±SEM) total number of food trough head entries emitted during the seven conditioning 
and the CS-only sessions for groups receiving no treatment prior to each conditioning session and AP-5 
prior to the CS-only session. 
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Figure 12: Mean (±SEM) CS minus pre-CS difference scores for groups receiving no treatment prior to 
each conditioning session and NBQX prior to the CS-only session. ♦ represents significant increase 
across the seven conditioning sessions. 
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Figure 13: Mean (±SEM) total number of food trough head entries emitted during the seven conditioning 
and the CS-only sessions for groups receiving no treatment prior to each conditioning session and NBQX 
prior to the CS-only session. 
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Figure 14: Mean (±SEM) CS minus pre-CS difference scores for groups receiving no treatment prior to 
each conditioning session and AP-5 or AP-5/NBQX combination prior to the CS-only session. ♦ 
represents a significant increase across the seven conditioning sessions. The arrows represent significant 
differences from the vehicle and 0.03125 µg AP-5 groups, p < 0.05. 
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Figure 15: Mean (±SEM) total number of food trough head entries emitted during the seven conditioning 
and the CS-only sessions for groups receiving no treatment prior to each conditioning session and AP-5 
or AP-5/NBQX combination prior to the CS-only session. 
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Chapter 3. 
 
 Discussion 
 
This dissertation tested the hypothesis that blockade of either metabotropic or NMDA and/or 
AMPA receptors in the VTA impairs the expression of food-based conditioned approach learning. The 
findings here described support this hypothesis. More specifically, bilateral microinjections of the 
metabotropic glutamate receptor antagonist MCPG into the VTA did not alter the expression of learned 
approach whereas the injection of the combined NMDA and AMPA receptor antagonists compound AP-
5/NBQX into the VTA significantly impaired the expression of reward-related learning. In short, these 
findings indicate that at least a part of the neural changes critical for the maintenance of an already 
learned reward-related behavior do occur in the VTA, and that these neural changes do involve NMDA 
and AMPA receptor stimulation.  
The findings of this dissertation summarize as follows: both the non-selective receptor antagonist 
kynurenic acid and the selective glutamate receptor antagonist AP-5/NBQX combination caused a dose-
related reduction in the CS minus pre-CS head entries difference scores – that is, they caused a 
reduction in the number of conditioned approach responses. When rats were treated with intra-VTA 
injections of the highest and medium doses of kynurenic acid, the CS minus pre-CS difference score 
decreased significantly.  Intra-VTA injections of the highest and second to highest AP-5/NBQX 
combination in rats produced similar results where the difference scores showed significant decreases. 
These findings indicate a decrease in the effectiveness of the CS to elicit conditioned approach and 
support our hypothesis that glutamate neurotransmission in the VTA is necessary for the expression of 
conditioned approach and reward-related learning in general (Zellner & Ranaldi, 2010).  
The observed impairment in the expression of conditioned approach after kynurenic acid or 
combined AP-5/NBQX treatments cannot adequately be explained as a general reduction in motoric 
activity. First, rats treated with kynurenic acid or AP-5/NBQX combinations emitted as many total head 
entries as their respective vehicle groups during the CS-only test session (under treatment).  This 
indicates that treatment with these glutamate receptor antagonists did not impair the rats’ abilities to enter 
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the food trough during the CS presentation. The observed reduction in conditioned approach after 
kynurenic acid or combined AP-5/NBQX treatment suggests a reduced efficiency of the CS to keep on 
eliciting approach. In other words, such findings support the notion that the key element impaired in our 
studies during the expression of conditioned approach was the CS ability to continue controlling behavior. 
Specifically, it appears that not only NMDA receptor stimulation in the VTA is necessary for the CSs to 
elicit incentive-motivational behavior (Zellner et al., 2009) (Ranaldi et al., 2011), but it also appears, at 
least in part, crucial for the maintenance of an already learned behavior. 
We also found that neither intra-VTA injections of the non-selective metabotropic glutamate 
receptor antagonist MCPG, nor AP-5 or NBQX alone caused reductions in the number of food trough 
head entries during the CS presentation. Although in general the magnitude of learning increased for all 
the rats in all treatment groups across the conditioning days, some distinctions among test compounds 
during the expression tests were noted.  
Animals in any of the four doses of MCPG tested showed on average minimal differences in their 
difference scores among the doses. Thus, MCPG did not produce any behavioral effect pertinent to the 
expression of conditioned approach suggesting that stimulation of metabotropic glutamate receptors in 
the VTA is presumably not necessary for the performance of this behavior. Indeed, there is some 
evidence that further corroborates that idea. Intraventricularly pre-injected rats with MCPG demonstrated 
to take longer time to reach the platform than vehicle rats in a Morris water maze paradigm (Bordi, 
Marcon, Chiamulera, & Reggiani, 1996). However, once the pre-treated rats learned the task, they 
reached the same level of performance as control animals (Bordi et al., 1996). Not only these findings 
suggest that MCPG disrupts the acquisition of Morris water maze learning, but it further supports our 
findings showing that once learning occurred, metabotropic glutamate receptors are not critical for the 
expression of an already learned behavior.  
Similarly to MCPG manipulation findings in our study, the different doses of NBQX produced 
minimal differences showing a slight trend toward a dose-related decline in approach responding. Thus it 
appears likely that NBQX attenuated, though minimally and non-significantly, the CS signal carried by 
glutamatergic inputs to the VTA. Consideration of the neurochemistry and neuroanatomy of the VTA 
suggests an interesting and possible explanation that may account for this event.   
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The VTA receives input via a variety of neurotransmitter systems including glutamatergic, 
GABAergic, serotonergic and cholinergic (Goldner, Dineley, & Patrick, 1997; Korotkova, Ponomarenko, 
Brown, & Haas, 2004). Assuming that AMPA receptor pool on DA cells and AMPA receptor pool on 
GABA cells are differentially sensitive to NBQX blockade, we can conjecture that a higher dose of NBQX, 
by sufficiently blocking AMPA receptor pools in both DA and GABA cells, would, by blocking excitation of 
GABAergic cells, indirectly disinhibit DA cells, and by blocking excitation of dopaminergic cells, directly 
inhibit DA cells. These two effects could hypothetically partially cancel each other out, leaving mesolimbic 
dopaminergic tone closer to baseline levels. This would result in less behavioral activation with levels 
similar to vehicle levels. And this is exactly what we observed (fig.12). 
Furthermore, a study conducted by You et al. (You et al., 2007) demonstrated that glutamate 
release in the VTA might play a critical role in cocaine seeking. They further reported that cocaine 
seeking was attenuated by intra-VTA irrigation with AP-5 alone, CNQX – a purported AMPA receptor 
antagonist – alone, or both antagonists simultaneously, suggesting that cocaine seeking is dependent on 
the stimulation of one or both NMDA and AMPA receptors. Contrary to their findings, in our study, 
blockade of AMPA receptors alone with NBQX did not reduce the expression of conditioned approach. 
Noteworthy to point that cocaine seeking is a learned behavior just as conditioned approach is. One 
possible explanation that may account for such discrepancy between these two studies is that they used 
CNQX whereas we used NBQX as AMPA receptor antagonist. Research shows that NBQX is a more 
selective blocker of AMPA receptors than CNQX (Yu & Miller, 1995); (Mead & Stephens, 1999); and that 
CNQX, although considered an AMPA receptor antagonist, has also a significant blocking action at the 
glycine site of NMDA receptors (Mead & Stephens, 1999; Sheardown, Nielsen, Hansen, Jacobsen, & 
Honore, 1990; Yu & Miller, 1995). Interestingly, evidence has documented that NBQX failed to block the 
expression of place-preference in an amphetamine-conditioned place preference study, whereas CNQX 
did not (Mead & Stephens, 1999) showing to effectively block the expression of place preference via its 
glycine antagonism action (Mead & Stephens, 1999). Thus, it appears plausible to infer that You et al. 
(You et al., 2007) observed significant decrease in cocaine seeking with CNQX because of its 
antagonistic action at the NMDA site receptor rather than AMPA receptor. Therefore, we can state with 
more assurance our argument that both NMDA and AMPA receptors are important for the expression of 
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conditioned approach, since in our study we used AP-5/NBQX treatment, which are both specific and 
selective NMDA and AMPA antagonists respectively.  
In a contrary pattern to our NBQX treatment findings, rats treated with AP-5 alone demonstrated 
an increasing trend in the learned approach responding. One possibility that may explain this is that 
NMDA receptor antagonist treatment in the VTA results in increasing DA neurotransmission in the NAcc 
(Johnson & North, 1992b), subsequently elevating motoric activity levels. 
While blockade of neither VTA NMDA nor VTA AMPA receptors alone reduced CS head entries 
during the CS-only session, there occurred significant reductions in CS minus pre-CS difference scores 
when animals were treated with NMDA and AMPA receptor antagonists combined, suggesting that under 
the condition when both of these ionotropic receptors are blocked the food-related CS is less effective to 
elicit conditioned approach responses. So, the relevant question here is why was conditioned approach 
reduced only when both NMDA and AMPA receptors were simultaneously blocked?  The development of 
LTP, including in the DA cells in the VTA, has been shown to be NMDA receptor dependent (Bonci & 
Malenka, 1999; Stuber et al., 2008). Under normal physiological conditions, the synaptic plasticity 
induced by NMDA receptor stimulation allows environmental signals to activate VTA DA cells. This 
stimulation of VTA neurons elicits an appetitive motivational state and triggers approach behaviors, which 
are both important for engaging the organism in reward-directed behavior, thereby increasing the animal’s 
encounters with reward-related stimuli. Simultaneously, increased DA release at the terminal regions 
allows for downstream associative processes to occur which underlie additional associative processes 
necessary in reward-related learning, such as stimulus-response and response-outcome dependent 
associations.   
As we discussed above, whereas the initiation of LTP is shown to be NMDA receptor dependent, 
the expression of LTP, on the other hand, appears to crucially involve AMPA receptors (Muller, Joly, & 
Lynch, 1988; M. Park, Penick, Edwards, Kauer, & Ehlers, 2004) (Lee et al., 2003). Based on the 
neurophysiology of LTP, and assuming that the expression of learning requires the expression of LTP, 
one might expect that blockade of AMPA receptors, which would consequently block the expression of 
LTP, would have inhibited, or at least impaired, the expression of conditioned approach in the present 
studies.  However, that is not the case. We found that AMPA receptor antagonism significantly reduced 
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conditioned approach only when it was accompanied by antagonism of NMDA receptors. One possible 
explanation for this is that our NBQX treatments did not fully antagonize the relevant AMPA receptor 
pools and that an effective antagonism of the pool was only achieved by simultaneous blockade of NMDA 
receptors with AP-5. Alternatively, we could also presume that at its highest dose – 4 µg/0.5 µl – AMPA 
receptors were fully blocked by NBQX and therefore reached a saturation point. Once that happened, 
other surrounding receptor types were left to function normally –possibly NMDA receptors in our case. 
Next, the blockade of a small pool of these NMDA receptors at their glutamate site would be the missing 
piece of the puzzle that once it occurred, it could be the reason why impairment of the expression of 
conditioned approach was observed only when antagonism of AMPA receptors was accompanied by the 
antagonism of NMDA receptors in the VTA.  
This would suggest that at least one component of AMPA receptor postsynaptic effects require 
NMDA receptor stimulation, an idea that is supported by other work (Shi et al., 1999) (Lopez, Gamache, 
Schneider, & Nader, 2015). Clearly, more research is needed to investigate and understand the complex 
interplay between NMDA and AMPA receptors in the VTA in the mediation of food reward-related learning 
processes.  
Here, NMDA receptor stimulation in the VTA, at least alone, proved, again, not to be necessary 
for expression of reward-related learning. This finding is supported by other studies in our lab (Zellner, 
2008) (Ranaldi et al., 2011), and is also similar to other studies which blocked NMDA receptors in the 
NAcc (Kelley et al., 1997) (Di Ciano et al., 2001) (Hernandez, Andrzejewski, Sadeghian, Panksepp, & 
Kelley, 2005). This was indicated by the fact that animals did not significantly reduce their learned 
approach responses on the final session after pre-treatment with AP-5. The fact that isolated NMDA 
receptor antagonism did not impair the expression of conditioned approach is consonant with part of the 
rationale that led to our hypothesis – once glutamatergic synapses carrying environmental stimuli-related 
signals have been strengthened, in other words acquisition of learning occurred, activation of VTA DA 
cells is no longer dependent on NMDA receptor stimulation (at least not alone) during the expression 
phase. Thus, the performance of conditioned approach learning would more likely be dependent on some 
other mechanism, possibly AMPA receptor stimulation, as we have previously discussed. 
Other studies have assessed the involvement of glutamate receptors in reward-related learning. 
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Our lab tested the effects of intra-VTA AP-5 in animals acquiring or maintaining a learned food-reward 
operant response and found that it blocked acquisition, but not expression, of this response (Zellner et al., 
2009).  Furthermore, in a conditioned approach response procedure identical to the current one, intra-
VTA AP-5 blocked the acquisition of learning but, again, not the expression of the behavior (Zellner et al., 
2009) (Ranaldi et al., 2011). Others have found a comparable effect; for example, an NMDA receptor 
antagonist manipulation into the VTA blocked the development of morphine place preference (Harris et 
al., 2004), whereas only a concomitant treatment of NMDA and AMPA receptor antagonists effectively 
interfered with the expression of conditioned place preference (Harris et al., 2004). Not only this indicates 
that NMDA receptors are crucial for the acquisition of reward-related learning, but also emphasizes that 
NMDA receptors alone do not account for the expression of reward-related learning processes to occur. 
You and colleagues (You et al., 2007) demonstrated that irrigation of the VTA with AP-5 through a 
microdialysis probe attenuated context-induced cocaine-seeking, suggesting that by itself, NMDA 
receptor stimulation may play a significant role in expression of reward-related learning.  As mentioned 
previously, this study also demonstrated the same effect when an AMPA antagonist was applied and 
when NMDA and AMPA antagonists were applied simultaneously (You et al., 2007).  Similarly, a 
combination of AMPA and NMDA receptor antagonists reduced reinstatement of cocaine seeking elicited 
by cues in a Pavlovian cue-triggered drug-seeking paradigm (Backstrom & Hyytia, 2006; Mahler, Smith, & 
Aston-Jones, 2013). In contrast, Solecki and colleagues (Solecki et al., 2013) showed that in a cue-
induced cocaine-seeking paradigm, VTA infusion of AP-5 failed to affect either cocaine seeking or phasic 
DA release in terminal regions. As one can note, the precise roles of VTA AMPA and VTA NMDA 
receptors, specifically in the expression of reward-related learning phenomena, as well as the complex 
interaction between these ionotropic receptors, remains to be fully understood. 
Other neurotransmitters in the VTA may also be involved in the expression of reward-related 
learning. For example, intra-VTA injections of scopolamine, a muscarinic acetylcholine receptor 
antagonist, significantly reduced lever pressing during acquisition of this task, but once the task was 
learned, had no effect on its maintenance (Sharf & Ranaldi, 2006) (Sharf et al., 2006). Also, a new stream 
of studies involving the manipulation of orexin – a neuropeptide that regulates arousal, wakefulness and 
appetite (Halford & Blundell, 2000) (Wise, 2006) – has demonstrated similar effects to the ones previously 
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reported. Orexin antagonism significantly attenuated the expression of cue-induced reinstatement of 
cocaine-seeking in rats (R. J. Smith, See, & Aston-Jones, 2009), reduced heroin self-administration and 
heroin seeking elicited by cues (R. J. Smith & Aston-Jones, 2012), decreased the expression of 
amphetamine sensitization (Quarta, Valerio, Hutcheson, Hedou, & Heidbreder, 2010), and also reduced 
the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-
conditioned reward (Hutcheson et al., 2011).  
This would suggest that other neurochemicals may also play an important role in the expression 
of reward-related learning. Evidently, more research is necessary to investigate and better comprehend 
the convoluted interaction between other neurochemicals and glutamate receptors in order to shed light 
on which elements are crucial for the expression of conditioned approach in reward-related learning.  
Besides indicating a decrease in the effectiveness of the CS to elicit conditioned approach, our findings 
could also possibly indicate that antagonism of NMDA and AMPA receptors in the VTA can inhibit the 
capacity of a light CS to elicit conditioned approach responses.  This suggests that an environmental 
glutamate signal acting at ionotropic glutamate receptors in the VTA mediates the control of food 
associated CSs to activate approach-eliciting neural substrates, perhaps through phasic activation of VTA 
DA cells. 
Another possibility is that the antagonism of both ionotropic glutamate receptors in the VTA 
reduced the performance of the conditioned approach behavior not because it blocked a glutamate signal 
(i.e., phasic DA activation) but because it reduced tonic DA activity.  However, if this was the case one 
might have expected reduced activity in general which would have been manifested in our procedure as a 
reduced number of total head entries.  We found that total head entries were not significantly lower in 
antagonist-treated groups as opposed to vehicle groups making this explanation not likely.   
In a more specific setting such as the neurochemical level under which the impairment of this 
conditioned approach performance occurred, it is possible that interference with the expression of 
learning was more due to effects on GABA neurons than on DA neurons. Conceivably, AP-5 and NBQX 
could have blocked synaptic transmission therefore disrupting synaptic plasticity on GABA cells, which in 
turn would have affected the behavioral expression of the learned response. DA neurons and GABA 
neurons in the VTA exhibit similar AMPA/NMDA current ratios (Bonci & Malenka, 1999) indicating that 
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GABA cells also possess NMDA and AMPA receptors. However, while DA cells demonstrate LTP 
following paired pulse stimulation, GABA cells did not. In contrast, they showed LTD (Bonci & Malenka, 
1999). This is in accordance with studies done in the hippocampus showing that excitatory synapses, at 
least on majority of GABA cells, do not express LTP (Nugent, Hwong, Udaka, & Kauer, 2008). As 
previously noted, based on the neurophysiology of LTP which accounts NMDA receptors for the induction 
of LTP (M. A. Musgrave et al., 1993) (Muller et al., 1988) and AMPA receptors for the expression of LTP 
(Mead & Stephens, 2003) (Nicoll, 2003) (Lee et al., 2003) (Malinow & Malenka, 2002), and assuming that 
the expression of learning requires the expression of LTP, it is plausible to argue that blockade of NMDA 
and AMPA receptors on GABA cells would also block the expression of LTP. However, because NMDA 
and AMPA receptor antagonism would most likely not affect LTP on GABA cells, a blockade of GABA 
neuron potentiation cannot account for our findings.  
In summary, intra-VTA microinjections of kynurenic acid or AP-5/NBQX combinations significantly 
reduced conditioned approach responding but similar treatments with MCPG, AP-5 alone and NBQX 
alone did not. These results suggest that performance of reward-related learning, such as conditioned 
approach, is necessarily dependent on the stimulation of NMDA or AMPA receptors in the VTA.  
Thus, the present findings contribute to extend our knowledge and further deepen our 
understanding of the neural mechanisms underlying reward-related learning associations in general, and 
also in regards to pathological behaviors based on stimulus-stimulus association disorders such as drug 
and food addiction. As such, additional research into intracellular processes critical for the establishment 
and performance of reward-related learning behaviors appear to be deemed necessary and will enable us 
to answer the question that we posed initially – what is critical for the occurrence of expression of reward-
related learning once glutamate signals have already been strengthened? As discussed earlier, a wealth 
of evidence from different lines of research demonstrates that LTP is likely to be dependent on AMPA 
receptors, and that once the stimulus-stimulus association is formed and learned by the organism, an 
alternative neural mechanism appears to “take charge” and be responsible for the expression of such 
learning. Gathering evidence and theorizing plausible outcomes in light of our findings will increase our 
understanding of brain mechanisms that contribute to the maintenance of drug or food conditioned 
approach and lead to novel pharmacotherapeutic treatment strategies. 
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Reflections on Glutamate-Dopamine interactions in Reward-Related Learning and their Social 
Implications  
 
Traditionally, reward-related learning research in neuroscience has focused on mechanisms 
involving dopamine. It is only more recently that it has been realized that glutamate also plays a central 
role in processes underlying the acquisition and performance of conditioned associations in the addiction 
field including reinforcement, sensitization, habit learning and reinforcement learning, context 
conditioning, craving and relapse. 
In the past few years, major progress has been made towards understanding how glutamate acts 
and interacts with other transmitters (in particular, dopamine) in the context of processes underlying 
reward-related learning.  
It appears that while many actions of glutamate derive their importance from a stimulatory 
interaction with the dopaminergic system, there are some glutamatergic mechanisms that contribute to 
learning independent of dopaminergic systems. Among those, context-specific aspects of behavioral 
determinants (i.e. control over behavior by conditioned stimuli) appear to heavily depend on glutamatergic 
transmission, and it is these glutamatergic mechanisms that may be responsible for plastic changes in the 
brain that lead to learned associations.  
It is clear that neither dopamine nor glutamate alone mediate processes underlying the 
acquisition and expression of learned approach. While the consideration of other potentially important 
transmitters such as the endogenous opioids, GABA, acetylcholine, noradrenaline, or even 
cholecystokinin are beyond the scope of this dissertation topic, it is worth to briefly consider the 
interactions between dopamine and glutamate in the context of reward-related learning processes. 
The mesocorticolimbic dopamine system is intricately connected with glutamatergic structures or 
their efferents. Both the cell body region in the VTA and the terminal region in the nucleus accumbens      
receive massive glutamatergic input from several corticolimbic structures such as PFC, amygdala and 
hippocampus (Christie, Summers, Stephenson, Cook, & Beart, 1987;Kelley, Domesick, & Nauta, 1982), 
structures that have been implicated in aspects of reward evaluation, conditioning and learning (Everitt, 
Morris, O'Brien, & Robbins, 1991; Everitt et al., 1999). The interaction between glutamate and dopamine 
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in VTA is rather complex, but in more simplified terms, glutamatergic input to the VTA increases the 
activity of dopaminergic cells and enhances dopamine release in the nucleus accumbens (Tzschentke, 
2001; Tzschentke & Schmidt, 2000).  
Although dopamine affects glutamatergic transmission by modulating glutamatergic signals in the 
nucleus accumbens originating from the amygdala and hippocampus (Floresco, Blaha, Yang, & Phillips, 
2001), some glutamatergic mechanisms appear to be independent of dopaminergic mechanisms. For 
example, it has been demonstrated that in mice lacking mGluR5, cocaine does not produce locomotor-
stimulant effects and lacks rewarding effects, as evidenced by an absence of cocaine self-administration 
behavior (Chiamulera et al., 2001). This suggests that the deficits in the mutant mice were not secondary 
to changes in the dopaminergic system but were solely due to changes in glutamatergic signaling. 
As previously mentioned, glutamate neurotransmission appears to be involved in a series of 
reward-related learning processes, including drug addiction. After sensitizing treatment schedules with 
drugs of abuse, repeated cocaine or amphetamine administration was shown to enhance the 
responsiveness to glutamatergic stimulation of mesolimbic dopamine neurons and to reduce the 
responsiveness to glutamatergic stimulation of nucleus accumbens neurons (White, Hu, Zhang, & Wolf, 
1995, X. F. Zhang, Hu, White, & Wolf, 1997), to alter the expression of glutamate receptor subunits/splice 
variants, in particular, in the mesolimbic system (Churchill, Swanson, Urbina, & Kalivas, 1999, Fitzgerald, 
Ortiz, Hamedani, & Nestler, 1996), and to result in increased glutamate releasability in the accumbens 
(Pierce, Bell, Duffy, & Kalivas, 1996, Reid & Berger, 1996). Taken together, this shows that repeated 
psychomotor stimulant administration can alter responsiveness of the mesoaccumbens DA system to 
glutamate suggesting the sensitization phenomenon to be intrinsically associated with alterations in 
glutamate transmission of the mesoaccumbens DA pathway. This further explains that the behavioral 
sensitization developed under drug addiction and certain of its neuronal correlates can be prevented by 
glutamate antagonists, such as AP-5 or NBQX or both, suggesting not only an integral role for glutamate 
systems in the sensitization processes, but also highlighting the importance of glutamate in the 
expression of reward-related learning. 
In reinforcement learning for example, glutamatergic mechanisms in the nucleus accumbens core 
appear to be involved in response-reinforcement learning in the acquisition of a lever-press task to obtain 
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food reward (Kelley et al., 1997). For example, injection of the NMDA receptor antagonist AP-5 into the 
accumbens core impaired the acquisition (but not the expression) of this task, while leaving feeding and 
locomotor responses and the formation of stimulus–reward associations intact.  
In addition, recent brain imaging studies in human addicts have shown that the presentation or 
mental representation of US-related cues can trigger craving and is associated with increased activity in 
the amygdala and prefrontal cortex (Childress et al., 1999, Wexler et al., 2001). The increased activity in 
these areas could result in increased glutamatergic transmission in the accumbens, which nicely fits the 
emerging picture on the role of nucleus accumbens glutamate in reinstatement of drug-seeking behavior 
derived from animal studies. Another line of evidence showing the role of glutamatergic transmission in 
reinstatement of drug-seeking behavior comes from the work of Vorel et al. (Vorel et al., 2001) who 
showed that electrical stimulation with physiologically relevant parameters of the ventral subiculum of the 
hippocampal formation potently reinstates cocaine-seeking behavior. Moreover, it was further shown that 
comparable reinstatement effects could be obtained by intra-VTA infusion of NMDA, and that stimulation-
induced reinstatement was completely blocked by microinfusion of kynurenic acid into the VTA (Vorel et 
al., 2001). This is in agreement with our findings, which showed that performance of learning was 
significantly impaired by intra-VTA kynurenic acid treatment.  
 Altogether, these studies highlight the importance to expand our knowledge in the reward-related 
learning field, and most importantly, they further corroborate our hypothesis that the role of glutamate 
neurotransmission is critical for the expression of conditioned approach learned behavior.  
 
Future directions  
 
 It is important to take into consideration that differences exist between different types of NMDA 
and AMPA receptor antagonists, as future work is suggested to further explore the role of glutamate 
neurotransmission in the VTA during the reward-related learning process. The studies cited herein have 
generally been those which used primarily AP-5 as a competitive NMDA antagonist, because different 
types of NMDA antagonists have different and at times opposite effects (Meltzer et al., 1997). For 
example, non-competitive NMDA antagonists including MK-801 and phencyclidine (PCP) both operate 
through a different neurochemical mechanism – they block the ion channel pore of the receptor (Kew & 
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Kemp, 2005), thus only having effects when the channels have been activated – increasing firing rate and 
bursting VTA DA cells, which competitive antagonists CGS 19755 and (+-) CPP either have no effect or 
non-significantly reduce activity (French, Mura, & Wang, 1993). Another example is the non-competitive 
AMPA receptor antagonist CNQX, which is found to operate at both on the glutamate and the glycine site 
of NMDA receptors (Mead & Stephens, 1999), besides acting on glutamate AMPA receptor sites. Thus, 
for future research, it becomes necessary to keep the antagonists in different categories – simply 
because findings for one type of antagonists do not necessarily imply similar and valid findings for 
another.  
 Furthermore, as future work is conducted on the role of VTA NMDA and VTA AMPA receptors in 
the expression of reward-related learning, it will be interesting to determine if the same treatment effect 
can also be found in other regions that comprise the mesolimbic system, namely the NAcc core and shell, 
lateral habenula or amygdala for example.  
 In short, these are alternate directions that could branch out from our originating hypothesis, and 
eventually lead to further and deeper understanding of the reward-related learning mechanisms.  
Conclusion 
 
 Altogether, the results of the experiments described in this dissertation contribute to the reward-
related learning field being evidence supporting the hypothesis with which this study originated. The 
results herein suggest that glutamate neurotransmission in the VTA is critical for the expression of 
conditioned approach in reward-related learning to occur, more specifically NMDA and AMPA receptors. 
It would be interesting to see future studies that can extend from these experiments, thereby adding to a 
growing body of literature which we hope will eventually lead us to a fuller and more comprehensive 
knowledge of the plasticity that underlies the neural mechanisms of the expression and maintenance of 
learned approach. This would potentially support the development and contribute to pharmacotherapeutic 
strategies for disorders based on the pathophysiology that arises from maladaptations in this neural 
circuit. 
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